Prevention of thrombosis following deep arterial injury in rats by bovine activated protein C requiring co-administration of bovine protein S

Thrombosis and Haemostasis

Volumn 90, Issue 2, 2003, Pages 227-234

  Malm, Karl ^a   Dahlbäck, Björn ^b   Arnljots, Björn ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b University Hospital Malmö   (Sweden)

Author keywords

Activated protein C; Animal model; Bleeding; Protein S; Thrombosis

Indexed keywords

ACTIVATED PROTEIN C; PROTEIN S;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTERIOTOMY; ARTERY CLAMP; ARTERY INJURY; ARTERY THROMBOSIS; ARTICLE; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; BOLUS INJECTION; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORONARY REPERFUSION; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; ENDARTERECTOMY; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; MALE; NONHUMAN; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RAT; VASCULAR PATENCY; VASCULAR SUTURE;

EID: 0042563262     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH03-03-0174     Document Type: Article

References (34)

1. Dahlback B. Blood coagulation. Lancet 2000; 355: 1627-32.
2. Dahlback B, Stenflo J. The protein C anticoagulant system. In: The Molecular Basis of Blood Diseases. Stamatoyannopoulos, Majerus, Perlmutter, Varmus, eds: WB Saunders 2001; 614-56.
3. Esmon CT. Regulation of blood coagulation. Biochim Biophys Acta 2000; 1477: 349-60.
4. Lane DA, Mannucci PM, Bauer KA, et al. Inherited thrombophilia: Part 1. Thromb Haemost 1996; 76: 651-62.
5. Lane DA, Mannucci PM, Bauer KA, et al. Inherited thrombophilia: Part 2. Thromb Haemost 1996; 76: 824-34.
6. Shen L, Dahlback B. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J Biol Chem 1994; 269: 18735-8.
7. Arnljots B, Dahlback B. Protein S as an in vivo cofactor to activated protein C in prevention of microarterial thrombosis in rabbits. J Clin Invest 1995; 95: 1987-93.
8. Arnljots B, Dahlback B. Antithrombotic effects of activated protein C and protein S in a rabbit model of microarterial thrombosis. Arterioscler Thromb Vasc Biol 1995; 15: 937-41.
9. Walker FJ. Regulation of bovine activated protein C by protein S: The role of the cofactor protein in species specificity. Thromb Res 1981; 22: 321-7.
10. Solymoss S, Tucker MM, Tracy PB. Kinetics of inactivation of membrane-bound factor Va by activated protein C. Protein S modulates factor Xa protection. J Biol Chem 1988; 263: 14884-90.
11. Tans G, Rosing J, Thomassen MC, Heeb MJ, Zwaal RF, Griffin JH. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 1991; 77: 2641-8.
12. He X, Dahlback B. Molecular cloning, expression and functional characterization of rabbit anticoagulant vitamin-K-dependent protein S. Eur J Biochem 1993; 217: 857-65.
13. Rosing J, Hoekema L, Nicolaes GA, Thomassen MC, Hemker HC, Varadi K, et al. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem 1995; 270: 27852-8.
14. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709.
15. Arnljots B, Bergqvist D, Dahlback B. Inhibition of microarterial thrombosis by activated protein C in a rabbit model. Thromb Haemost 1994; 72: 415-20.
16. Jackson CV, Bailey BD, Shetler TJ. Pharmacological profile of recombinant, human activated protein C (LY203638) in a canine model of coronary artery thrombosis. J Pharmacol Exp Ther 2000; 295: 967-71.
17. Foo RS, Gershlick AH, Hogrefe K, et al. Inhibition of platelet thrombosis using an activated protein C-loaded stent: In vitro and in vivo results. Thromb Haemost 2000; 83: 496-502.
18. Sakamoto T, Ogawa H, Yasue H, et al. Prevention of arterial reocclusion after thrombolysis with activated protein C. Comparison with heparin in a canine model of coronary artery thrombosis. Circulation 1994; 90: 427-32.
19. Gruber A, Griffin JH, Harker LA, Hanson SR. Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model. Blood 1989; 73: 639-42.
20. Gruber A, Hanson SR, Kelly AB, et al. Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis. Circulation 1990; 82: 578-85.
21. Araki H, Nishi K, Ishihara N, Okajima K. Inhibitory effects of activated protein C and heparin on thrombotic arterial occlusion in rat mesenteric arteries. Thromb Res 1991; 62: 209-16.
22. Yamashita T, Matsuoka A, Funatsu A, Yamamoto J. The antithrombotic effect of human activated protein C on He-Ne laser- induced thrombosis in rat mesenteric microvessels. Thromb Res 1994; 75: 33-40.
23. Smirnov MD, Pyzh MV, Borovikov DV, et al. Low doses of activated protein C delay arterial thrombosis in rats. Thromb Res 1990; 57: 645-50.
24. Hashimoto M, Watanabe S, Oiwa K, et al. Enhanced thrombolysis induced by argatroban or activated protein C in the presence or absence of staphylokinase, measured in an in vivo animal model using mesenteric arterioles. Haemostasis 2001; 31: 80-9.
25. Hashimoto M, Yamashita T, Oiwa K, Watanabe S, Giddings JC, Yamamoto J. Enhancement of endogenous plasminogen activator-induced thrombolysis by argatroban and APC and its control by TAFI, measured in an arterial thrombolysis model in vivo using rat mesenteric arterioles. Thromb Haemost 2002; 87: 110-3.
26. Stenflo J. A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization. J Biol Chem 1976; 251: 355-63.
27. Stenflo J, Jonsson M. Protein S, a new vitamin K-dependent protein from bovine plasma. FEBS Lett 1979; 101: 377-81.
28. Dahlback B, Hildebrand B, Linse S. Novel type of very high affinity calcium-binding sites in beta- hydroxyasparagine-containing epidermal growth factor-like domains in vitamin K-dependent protein S. J Biol Chem 1990; 265: 18481-9.
29. Soderstrom T, Hedner U, Arnljots B. Active site-inactivated factor VIIa prevents thrombosis without increased surgical bleeding: Topical and intravenous administration in a rat model of deep arterial injury. J Vasc Surg 2001; 33: 1072-9.
30. Acland RD. Microsurgery Practice Manual. In. St. Louis: Mosby 1980; 58-9.
31. Marmur JD, Rossikhina M, Guha A, et al. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest 1993; 91: 2253-9.
32. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A 1989; 86: 2839-43.
33. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134: 1087-97.
34. Malm K, Dahlback B, Arnljots B. Low-molecular-weight heparin (Dalteparin) effectively prevents thrombosis in a rat model of deep arterial injury. Plast Reconstr Surg 2003; 111(5): 1659-66.